BRPI0810472A2 - Métodos relacionados à glicosilação da superfície celular - Google Patents

Métodos relacionados à glicosilação da superfície celular

Info

Publication number
BRPI0810472A2
BRPI0810472A2 BRPI0810472-7A2A BRPI0810472A BRPI0810472A2 BR PI0810472 A2 BRPI0810472 A2 BR PI0810472A2 BR PI0810472 A BRPI0810472 A BR PI0810472A BR PI0810472 A2 BRPI0810472 A2 BR PI0810472A2
Authority
BR
Brazil
Prior art keywords
glycosilation
cell surface
methods related
methods
cell
Prior art date
Application number
BRPI0810472-7A2A
Other languages
English (en)
Inventor
Brian Edward Collins
Carlos J Bosques
Xiangping Zhu
Dorota A Bulik
Lakshmanan Thiruneelakantapillai
Ian Christopher Parsons
Rajeev Chilakuru
Ganesh Venkataraman
Zachary Schriver
Original Assignee
Momenta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc
Publication of BRPI0810472A2 publication Critical patent/BRPI0810472A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0810472-7A2A 2007-04-16 2008-04-15 Métodos relacionados à glicosilação da superfície celular BRPI0810472A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92365507P 2007-04-16 2007-04-16
PCT/US2008/060355 WO2008128228A1 (en) 2007-04-16 2008-04-15 Methods related to cell surface glycosylation

Publications (1)

Publication Number Publication Date
BRPI0810472A2 true BRPI0810472A2 (pt) 2014-11-11

Family

ID=39537522

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810472-7A2A BRPI0810472A2 (pt) 2007-04-16 2008-04-15 Métodos relacionados à glicosilação da superfície celular

Country Status (11)

Country Link
US (1) US8338088B2 (pt)
EP (2) EP2511705A1 (pt)
JP (1) JP5175336B2 (pt)
CN (1) CN101675339B (pt)
AU (1) AU2008240081A1 (pt)
BR (1) BRPI0810472A2 (pt)
CA (1) CA2682744C (pt)
DK (1) DK2135081T3 (pt)
ES (1) ES2399940T3 (pt)
RU (1) RU2475751C2 (pt)
WO (1) WO2008128228A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2743181A1 (en) * 2008-12-19 2010-06-24 Momenta Pharmaceuticals, Inc. Methods related to modified glycans
US20120329709A1 (en) * 2009-05-26 2012-12-27 Brian Edward Collins Production of glycoproteins
US20120196310A1 (en) 2009-10-02 2012-08-02 Christiane Jaeger A-fucosylation detection in antibodies
EP2507627A2 (en) * 2009-12-04 2012-10-10 Momenta Pharmaceuticals, Inc. Antennary fucosylation in glycoproteins from cho cells
EP2555801A4 (en) * 2010-04-07 2014-02-26 Momenta Pharmaceuticals Inc SELECTION AND USE OF HOST CELLS FOR THE MANUFACTURE OF GLYCOPROTEINS
WO2011127322A1 (en) 2010-04-07 2011-10-13 Momenta Pharmaceuticals, Inc. High mannose glycans
EP2686671A4 (en) 2011-03-12 2015-06-24 Momenta Pharmaceuticals Inc N-GLYCANES CONTAINING N-ACETYLHEXOSAMINE IN GLYCOPROTEIN PRODUCTS
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
US20150141620A1 (en) 2012-06-01 2015-05-21 Momenta Pharmaceuticals, Inc. Methods related to rituximab
US20150147317A1 (en) 2012-06-01 2015-05-28 Momenta Pharmaceuticals, Inc. Methods related to bevacizumab
EP2877589B1 (en) 2012-07-26 2024-03-06 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
CN102809655B (zh) * 2012-08-26 2014-05-21 玉溪沃森生物技术有限公司 一种脑膜炎球菌多糖结合疫苗成品各群多糖含量的测定方法
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
EP2900264A4 (en) * 2012-09-26 2016-05-25 Momenta Pharmaceuticals Inc GLYKOPROTEINZUBEREITUNGEN
UY35343A (es) * 2013-02-26 2014-09-30 Bayer Healthcare Llc Formulaciones y procedimientos para la producción de proteína recombinante aumentada
HK1207960A1 (en) 2013-03-12 2016-02-19 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
ES2802274T3 (es) 2013-05-02 2021-01-18 Momenta Pharmaceuticals Inc Glicoproteínas sialiladas
WO2014186310A1 (en) 2013-05-13 2014-11-20 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CN105699497B (zh) * 2014-11-24 2019-04-09 中国科学院大连化学物理研究所 应用伴刀豆凝集素材料富集糖蛋白或糖肽中聚糖的方法
EP3298135B1 (en) * 2015-05-18 2023-06-07 The Regents of the University of California Systems and methods for predicting glycosylation on proteins
EP3397282A4 (en) 2015-12-30 2019-08-07 Momenta Pharmaceuticals, Inc. METHODS RELATING TO BIOLOGICA
US20200088737A1 (en) * 2016-01-27 2020-03-19 J-Oil Mills, Inc. Method for Detecting Glycoprotein
US11035862B2 (en) 2016-08-17 2021-06-15 Agilent Technologies, Inc. Use of mild electrophiles to reduce artifacts in analyzing glycans released from glycoproteins or glycopeptides
CA3059584A1 (en) * 2017-04-14 2018-10-18 Juno Therapeutics, Inc. Methods for assessing cell surface glycosylation
TWI722535B (zh) 2018-08-21 2021-03-21 美商美國禮來大藥廠 測定蛋白質或肽濃度的方法及其用途
US12595454B2 (en) 2018-09-06 2026-04-07 Momenta Pharmaceuticals, Inc. Methods of continuous cell culture
US20210353752A1 (en) 2018-10-11 2021-11-18 Momenta Pharmaceuticals, Inc. Treatment with highly silylated igg compositions
IL284374B2 (en) 2018-12-31 2025-10-01 Momenta Pharmaceuticals Inc Methods for producing ozatekinumab
CN111243677B (zh) * 2020-01-07 2023-04-14 北京唐颐惠康生物医学技术有限公司 一种基于细胞质量保证的时间控制方法及系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
IL129767A0 (en) 1996-12-12 2000-02-29 Prolume Ltd Apparatus and method for detecting and identifying infectious agents
US6506598B1 (en) * 1999-04-26 2003-01-14 Genentech, Inc. Cell culture process
AU2001245838A1 (en) * 2000-03-17 2001-10-03 Gemini Science, Inc. Soluble mast cell function associated antigen (mafa) pharmaceutical compositionsand methods of making and using them
HUP0002557A3 (en) * 2000-07-03 2004-08-30 Solvo Biotechnologiai Kft Simple quantitative fluorescent assay method for determining the activity of transport proteins of interest
AU2002950878A0 (en) * 2002-08-20 2002-09-12 Proteome Systems Intellectual Property Pty Ltd Method for diagnosing disorders
AU2003901316A0 (en) * 2003-03-21 2003-04-03 The Royal Alexandra Hospital For Children Regulation of cell surface proteins
US20110136147A1 (en) * 2004-09-08 2011-06-09 Pierce J Michael Methods of identifying tumor associated glycoproteins
WO2007012695A2 (en) * 2005-07-11 2007-02-01 Glykos Finland Oy Tissue carbohydrate compositions and analysis thereof
US20070012695A1 (en) * 2005-07-15 2007-01-18 Formosa Saint Jose Corp. Convertible container for vehicle
WO2007011041A1 (ja) * 2005-07-22 2007-01-25 Kyowa Hakko Kogyo Co., Ltd. 遺伝子組換え抗体組成物
US7923538B2 (en) * 2005-07-22 2011-04-12 Kyowa Hakko Kirin Co., Ltd Recombinant antibody composition
ES2626080T3 (es) 2007-04-16 2017-07-21 Momenta Pharmaceuticals, Inc. Caracterización de N-glicanos utilizando exoglicosidasas
US7957132B2 (en) 2007-04-16 2011-06-07 Fried Stephen S Efficiently cool data centers and electronic enclosures using loop heat pipes

Also Published As

Publication number Publication date
JP2010525328A (ja) 2010-07-22
CA2682744C (en) 2015-10-06
WO2008128228A1 (en) 2008-10-23
US8338088B2 (en) 2012-12-25
CA2682744A1 (en) 2008-10-23
AU2008240081A1 (en) 2008-10-23
DK2135081T3 (da) 2013-03-11
CN101675339B (zh) 2014-04-16
CN101675339A (zh) 2010-03-17
RU2475751C2 (ru) 2013-02-20
ES2399940T3 (es) 2013-04-04
EP2511705A1 (en) 2012-10-17
US20100196940A1 (en) 2010-08-05
EP2135081B1 (en) 2012-12-05
RU2009141980A (ru) 2011-05-27
EP2135081A1 (en) 2009-12-23
JP5175336B2 (ja) 2013-04-03

Similar Documents

Publication Publication Date Title
BRPI0810472A2 (pt) Métodos relacionados à glicosilação da superfície celular
EP2005504A4 (en) ELECTROLYTE
EP2215246A4 (en) PROTEIN SCAFFOLDS
PT2173888T (pt) Resumo
DE102007063274B8 (de) Mikroskop
DK3118221T3 (da) Proteiner
BRPI0813775A2 (pt) Composição
EP2233838A4 (en) COOKER
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
EP2165942A4 (en) Plug structure
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
EP2129285A4 (en) Analyte sensor
ATE507350T1 (de) Überlaufbauwerk
BRPI0815203A2 (pt) gel contendo pirfenidona
DK2027150T3 (da) Allo-begrænsede peptid-specifikke t-celler
BRPI0814572A2 (pt) Célula de lítio
PT2182988E (pt) Composição radiofarmacêutica
BRPI0809678A2 (pt) Métodos
BRPI0811002A2 (pt) Composição biofertilizante
BRPI0820960A2 (pt) composição
DE112008000295A5 (de) Steckerstift
BRPI0813726A2 (pt) Célula de lítio
BRPI0815595A2 (pt) Composição antifúngica
DK2190865T3 (da) Hypoallergent molekyle

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]